Search results for "Microbio"

showing 10 items of 8741 documents

The impact of wildlife and environmental factors on hantavirus infection in the host and its translation into human risk

2023

Identifying factors that drive infection dynamics in reservoir host populations is essential in understanding human risk from wildlife-originated zoonoses. We studied zoonotic Puumala orthohantavirus (PUUV) in the host, the bank vole ( Myodes glareolus ), populations in relation to the host population, rodent and predator community and environment-related factors and whether these processes are translated into human infection incidence. We used 5-year rodent trapping and bank vole PUUV serology data collected from 30 sites located in 24 municipalities in Finland. We found that PUUV seroprevalence in the host was negatively associated with the abundance of red foxes, but this process did no…

hantaviruksetesiintyvyysGeneral Immunology and MicrobiologymetsämyyräjyrsijätGeneral MedicinezoonoositriskitekijätpopulaatiodynamiikkaGeneral Biochemistry Genetics and Molecular Biologyzoonotic Puumala orthohantavirusjuvenile dilution effectPuumala-virustop–down trophic interactionsdilution effectGeneral Agricultural and Biological Sciencesluonnonvaraiset eläimetGeneral Environmental Science
researchProduct

Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM.

2020

Abstract Background In Europe, increases in HCV infection have been observed over the last two decades in MSM, making them a key population for recently acquired HCV. Alternative combinations of direct-acting antiviral agents against early HCV infection need to be assessed. Patients and methods In this pilot trial, MSM with recently acquired genotype 1 or 4 HCV infection were prospectively included and received 8 weeks of oral grazoprevir 100 mg and elbasvir 50 mg in a fixed-dose combination administered once daily. The primary endpoint was sustained virological response evaluated 12 weeks after the end of treatment (EOT) (SVR12). Secondary endpoints were the virological characterization of…

hepatitis C virusCyclopropanesMaleadverse eventmen who have sex with menHepacivirusmedicine.disease_causeSexual and Gender Minoritiesblood HIV RNA0302 clinical medicine[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesfollow-upClinical endpointMedicinePharmacology (medical)infections030212 general & internal medicinehepatitis ceducation.field_of_studySulfonamideshepatitis c rnaImidazolesvirus diseasesHepatitis Cvirologyhepatitis C virus genotype 13. Good healthEuropeInfectious DiseasesGrazoprevirRNA Viral030211 gastroenterology & hepatologyDrug Therapy CombinationMicrobiology (medical)medicine.medical_specialtyElbasvirGenotypeHepatitis C virusPopulationelbasvirAntiviral Agentsreinfection03 medical and health sciencesInternal medicineQuinoxalinesHumansHomosexuality MaleAdverse effecteducationplasmasuicideBenzofuransPharmacologybusiness.industrySurrogate endpointHIVgrazoprevirHepatitis C Chronicmedicine.diseaseAmidessurrogate endpoints[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyQuality of LifeCarbamatesbusinessThe Journal of antimicrobial chemotherapy
researchProduct

Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b

2021

HCV is an important cause of hepatocellular carcinoma (HCC). HCV NS5A domain-1 interacts with cellular proteins inducing pro-oncogenic pathways. Thus, we explore genetic variations in NS5A domain-1 and their association with HCC, by analyzing 188 NS5A sequences from HCV genotype-1b infected DAA-naïve cirrhotic patients: 34 with HCC and 154 without HCC. Specific NS5A mutations significantly correlate with HCC: S3T (8.8% vs. 1.3%, p = 0.01), T122M (8.8% vs. 0.0%, p &lt

hepatitis C virusLiver CirrhosisMaleCirrhosisvirusesHepacivirusViral Nonstructural ProteinsNS5Amedicine.disease_causeSeverity of Illness Indexgenetic variabilityMedicineLiver Neoplasmsvirus diseaseshepatocellular carcinomaMiddle AgedHepatitis CQR1-502Infectious DiseasesHepatocellular carcinomaHCVHost-Pathogen InteractionsFemaleDisease SusceptibilityCarcinoma HepatocellularGenotypeHepatitis C virusViremiaMicrobiologyArticleStructure-Activity RelationshipVirologyGenetic variationHumansGenetic variabilityNS5AneoplasmsAgedbusiness.industrycirrhosisSequence Analysis DNAbiochemical phenomena metabolism and nutritiongenotype 1bmedicine.diseaseSettore MED/17digestive system diseasesMutationCancer researchbusinessCarcinogenesisBiomarkersViruses
researchProduct

Scientific opinion on an application by Dow AgroSciences LLC (EFSA-GMO-NL-2012-106) for the placing on the market of genetically modified herbicide-t…

2017

Abstract Soybean DAS‐44406‐6 expresses 5‐enolpyruvyl‐shikimate‐3‐phosphate synthase (2mEPSPS), conferring tolerance to glyphosate‐based herbicides, aryloxyalkanoate dioxygenase (AAD‐12), conferring tolerance to 2,4‐dichlorophenoxyacetic acid (2,4‐D) and other related phenoxy herbicides, and phosphinothricin acetyl transferase (PAT), conferring tolerance to glufosinate ammonium‐based herbicides. The molecular characterisation data and bioinformatics analyses did not identify issues requiring assessment for food/feed safety. The agronomic and phenotypic characteristics revealed no relevant differences between soybean DAS‐44406‐6 and its conventional counterpart, except for pod count, seed cou…

herbicide toleranceVeterinary (miscellaneous)Plant ScienceTP1-1185010501 environmental sciences01 natural sciencesMicrobiology0404 agricultural biotechnologyRegulation 1829/2003TX341-6410105 earth and related environmental sciencesNutrition. Foods and food supplyChemical technologyfungifood and beverages04 agricultural and veterinary sciencesDAS‐44406‐6040401 food sciencesoybean (Glycine max cv. Maverick)Scientific OpinionSettore AGR/11 - Entomologia Generale E ApplicataAnimal Science and ZoologyParasitologyAAD‐122mEPSPSPATFood Science2mEPSPS; AAD‐12; DAS‐44406‐6; PAT; Regulation 1829/2003; herbicide tolerance; soybean (Glycine max cv. Maverick)
researchProduct

Scientific Opinion on an application by Syngenta (EFSA-GMO-DE-2009-66) for placing on the market of herbicide tolerant and insect resistant maize Bt1…

2015

Question number: EFSA-Q-2009-00444 on request from Competent Authority of Germany; The EFSA GMO Panel previously assessed the four single events combined to produce a four-event stack maize Bt11 × MIR162 × MIR604 × GA21 and did not identify safety concerns. In this opinion, the EFSA GMO Panel assesses the four-event stack maize and all its subcombinations independently of their origin. No new data on the single events, leading to modification of the original conclusions on their safety, were identified. The molecular, agronomic, phenotypic and compositional data on the four-event stack maize did not give rise to safety concerns and there is no reason to expect interactions between the singl…

herbicide tolerant and insect resistantVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]2405 ParasitologyinteractionContext (language use)Plant Sciencephenotypes GMOmaizeMicrobiologyGA21herbicide1110 Plant Sciencepestmaize (Zea mays)pesticide1106 Food Science2. Zero hungerbusiness.industryGMO2404 MicrobiologyMIR162stack10079 Institute of Veterinary Pharmacology and ToxicologyBt11MIR604pest resistanceSettore AGR/02 - Agronomia E Coltivazioni ErbaceeBiotechnology3401 Veterinary (miscellaneous)food safetySettore AGR/11 - Entomologia Generale E Applicata570 Life sciences; biologyAnimal Science and ZoologyParasitology1103 Animal Science and ZoologybusinessRelevant informationFood Science
researchProduct

Characterization of two Streptomyces coelicolor A3(2) small orfs from the major locus of histidine biosynthesis.

2009

histidine biosynthesisStreptomyces coelicolorSettore BIO/19 - Microbiologia Generale
researchProduct

Luis del Río y Lara y la constitución de la microbiología médica en España

1988

La Microbiologia mèdica es va consolidar a Espanya, com en la resta d'Europa, en els últims decennis del segle XIX. En el quinquenni comprés entre 1881 i 1885, es van dur a terme les primeres aplicacions de la nova ciència a la resolució de problemes mèdics com les epidèmies, tenint com a base la informació europea i algunes investigacions originals. Els últims anys del segle van veure la definitiva cristal·lització de la Microbiologia mèdica. Un dels seus màxims exponents va ser Luis del Riu i Lara i la seua obra “Elementos de Microbiología”. Investigador profundament coneixedor de les noves tècniques microbiològiques, la seua labor com a bacteriòleg ha quedat enfosquida per la seua intens…

historia de la medicinahistòria de la medicinaUNESCO::HISTORIA::Historia por especialidades::Historia de la medicina:CIENCIAS DE LA VIDA::Microbiología [UNESCO]:HISTORIA::Historia por especialidades::Historia de la medicina [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Microbiologíamicrobiologia mèdicamicrobiología médica
researchProduct

Emilio Fernández Galiano y la biología de los protozoos en España

2021

En els inicis del segle XX l'estudi dels protozous a Espanya estava delimitat a les espècies paràsites de l'home al qual causaven greus malalties. Emilio Fernández Galiano va estudiar protozoologia com a part del seu interés per la citologia i la histologia i podem dir que va introduir a Espanya l'estudi d'aquests microorganismes des de la visió del naturalista. Com a naturalista li van interessar els protozous i els seus moviments amb minuciositat, i fruit d'això va escriure el primer text en espanyol sobre la biologia d'aquests microorganismes, “Morfología y Biología de los Protozoos”, amb un contingut més enllà de l'interés mèdic-sanitari, desenvolupant una important activitat divulgativ…

historia de la medicinaprotozoologíahistòria de la medicinaUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología) ::Protozoología:CIENCIAS DE LA VIDA::Microbiología [UNESCO]UNESCO::HISTORIA::Historia por especialidades::Historia de la medicina:HISTORIA::Historia por especialidades::Historia de la medicina [UNESCO]:CIENCIAS DE LA VIDA::Biología animal (Zoología) ::Protozoología [UNESCO]microbiologia mèdicamicrobiología médicaprotozoologiaUNESCO::CIENCIAS DE LA VIDA::Microbiología
researchProduct

HUMAN MILK IS NOT “MERELY NUTRITIOUS”: HOW ITS BIOACTIVE ROLE CAN INFLUENCE CHILD HEALTH

2021

Maternal milk represents the best food for the newborn, providing specific physiologic advantages over the other sources of nutrition. It also contains many hundreds to thousands of bioactive molecules that protect against infection (i.e. IgA), inflammation (i.e. 5-methylthioadenosine) and contribute to eliciting strong immune responses in breastfed children (i.e. allergens or viral antigens). Quality and quantity of breast milk components may influence the development of infant body composition in the first years of life; in particular, it has been shown that a different composition of human oligosaccharides (HMOs) in overweight/obese women’s human milk can be correlated with her offspring…

hmoslcsh:R5-920bioactive compoundsbreastfeedingmicrobiotafood and beverageslcsh:Medicine (General)Euromediterranean Biomedical Journal
researchProduct

Transfer of Immunity from Mother to Offspring Is Mediated via Egg-Yolk Protein Vitellogenin.

2015

Insect immune systems can recognize specific pathogens and prime offspring immunity. High specificity of immune priming can be achieved when insect females transfer immune elicitors into developing oocytes. The molecular mechanism behind this transfer has been a mystery. Here, we establish that the egg-yolk protein vitellogenin is the carrier of immune elicitors. Using the honey bee, Apis mellifera, model system, we demonstrate with microscopy and western blotting that vitellogenin binds to bacteria, both Paenibacillus larvae – the gram-positive bacterium causing American foulbrood disease – and to Escherichia coli that represents gram-negative bacteria. Next, we verify that vitellogenin bi…

honey beestrans-generational immunityEgg proteinmedicine.disease_causebakteeritchemistry.chemical_compoundVitellogeninsbacterial pathogensimmuniteettibacterialcsh:QH301-705.5biologyfood and beveragesBees3. Good healthCell biologyFemaleVitellogeninsResearch Articlelcsh:Immunologic diseases. Allergyfood.ingredientanimal structuresImmunologyBlotting WesternMicrobiologyVitellogeninfoodImmune systemImmunityVirologyYolkGeneticsmedicineAnimalsMolecular BiologyEscherichia coliOvumfungiEgg Proteinsta1182Surface Plasmon Resonanceimmunitylcsh:Biology (General)chemistryImmunologybiology.proteinta1181bacteriaParasitologyPeptidoglycanlcsh:RC581-607vitellogeninPLoS pathogens
researchProduct